Mefloquine
A long-acting antimalarial. While effective, it is associated with neuropsychiatric side effects like anxiety or vivid dreams.
Dosage by Body Weight
Prophylaxis: 5 mg/kg once weekly. Treatment: 15-25 mg/kg as a split dose. Contraindicated in children with a history of seizures or psychiatric disorders.
- Body Weight
- 15-19 kg
- Dose
- 62.5 mg (quarter tablet)
- Frequency
- Once weekly (Prophylaxis)
- Tracking Notes
- Start 2 weeks before travel and continue for 4 weeks after.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| 15-19 kg | 62.5 mg (quarter tablet) | Once weekly (Prophylaxis) | Start 2 weeks before travel and continue for 4 weeks after. |
Formulation
Purpose
Treatment and prophylaxis of malaria in areas with resistant P. falciparum.
Generic Name
Mefloquine HydrochlorideBranded Drug Names
Mefloquine is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONMefloquine: Alcohol may increase dizziness, stomach upset, dehydration, or other side effects. Avoid or limit alcohol and follow medical advice.
Pregnancy
SAFE IF PRESCRIBEDMefloquine: Use during pregnancy only if prescribed after a healthcare provider weighs the benefits and risks.
Breast Feeding
SAFE IF PRESCRIBEDMefloquine: Use while breastfeeding only with healthcare provider guidance, especially for repeated or long-term treatment.
Driving
CAUTIONMefloquine: This medicine may cause dizziness, drowsiness, weakness, or blurred vision in some people. Avoid driving if affected.
Liver
CAUTIONMefloquine: Use with caution in liver disease and consult your healthcare provider if you have abnormal liver tests or jaundice.
Kidney
CAUTIONMefloquine: Use with caution in kidney disease because dose adjustment or monitoring may be needed for some patients.